Antiepileptic rufinamide and QTc interval shortening in a patient with long QT syndrome: case report.

Tapas MondalKristen SullivanSyam DivakaramenonRobert M Hamilton

Published in: European heart journal. Case reports (2020)

This case report highlights the potential benefits of rufinamide, a drug associated with mild QT shortening in normal individuals, to markedly reduce and normalize QT duration in a subject with LQTS1.

Keyphrases

case report
drug induced
emergency department
adverse drug